8FG8 | pdb_00008fg8

Catalytic domain of GtfB in complex with inhibitor 2-[(2,4,5-Trihydroxyphenyl)methylidene]-1-benzofuran-3-one


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.35 Å
  • R-Value Free: 
    0.233 (Depositor), 0.236 (DCC) 
  • R-Value Work: 
    0.205 (Depositor), 0.208 (DCC) 
  • R-Value Observed: 
    0.207 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 8FG8

Ligand Structure Quality Assessment 


This is version 1.2 of the entry. See complete history

Literature

Hydrogel-Encapsulated Biofilm Inhibitors Abrogate the Cariogenic Activity of Streptococcus mutans .

Ahirwar, P.Kozlovskaya, V.Nijampatnam, B.Rojas, E.M.Pukkanasut, P.Inman, D.Dolmat, M.Law, A.C.Schormann, N.Deivanayagam, C.Harber, G.J.Michalek, S.M.Wu, H.Kharlampieva, E.Velu, S.E.

(2023) J Med Chem 66: 7909-7925

  • DOI: https://doi.org/10.1021/acs.jmedchem.3c00272
  • Primary Citation Related Structures: 
    8FG8

  • PubMed Abstract: 

    We designed and synthesized analogues of a previously identified biofilm inhibitor IIIC5 to improve solubility, retain inhibitory activities, and to facilitate encapsulation into pH-responsive hydrogel microparticles. The optimized lead compound HA5 showed improved solubility of 120.09 μg/mL, inhibited Streptococcus mutans biofilm with an IC 50 value of 6.42 μM, and did not affect the growth of oral commensal species up to a 15-fold higher concentration. The cocrystal structure of HA5 with GtfB catalytic domain determined at 2.35 Å resolution revealed its active site interactions. The ability of HA5 to inhibit S. mutans Gtfs and to reduce glucan production has been demonstrated. The hydrogel-encapsulated biofilm inhibitor ( HEBI ), generated by encapsulating HA5 in hydrogel, selectively inhibited S. mutans biofilms like HA5 . Treatment of S. mutans -infected rats with HA5 or HEBI resulted in a significant reduction in buccal, sulcal, and proximal dental caries compared to untreated, infected rats.


  • Organizational Affiliation
    • Department of Integrative Biomedical and Diagnostic Sciences, Oregon Health and Science University, Portland, Oregon 97239, United States.

Macromolecule Content 

  • Total Structure Weight: 198.41 kDa 
  • Atom Count: 13,759 
  • Modeled Residue Count: 1,659 
  • Deposited Residue Count: 1,738 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Glucosyltransferase-I
A, B
869Streptococcus mutansMutation(s): 0 
Gene Names: gtfBSMU_1004
EC: 2.4.1.5
UniProt
Find proteins for P08987 (Streptococcus mutans serotype c (strain ATCC 700610 / UA159))
Explore P08987 
Go to UniProtKB:  P08987
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP08987
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 4 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
XV5
(Subject of Investigation/LOI)

Query on XV5



Download:Ideal Coordinates CCD File
D [auth A],
Q [auth B]
(2Z)-2-[(2,4,5-trihydroxyphenyl)methylidene]-1-benzofuran-3(2H)-one
C15 H10 O5
VVYKSKJYFAOSBP-UHFFFAOYSA-N
BTB
(Subject of Investigation/LOI)

Query on BTB



Download:Ideal Coordinates CCD File
E [auth A],
R [auth B]
2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL
C8 H19 N O5
OWMVSZAMULFTJU-UHFFFAOYSA-N
SO4
(Subject of Investigation/LOI)

Query on SO4



Download:Ideal Coordinates CCD File
AA [auth B]
BA [auth B]
CA [auth B]
DA [auth B]
EA [auth B]
AA [auth B],
BA [auth B],
CA [auth B],
DA [auth B],
EA [auth B],
F [auth A],
FA [auth B],
G [auth A],
H [auth A],
I [auth A],
J [auth A],
K [auth A],
L [auth A],
M [auth A],
N [auth A],
O [auth A],
S [auth B],
T [auth B],
U [auth B],
V [auth B],
W [auth B],
X [auth B],
Y [auth B],
Z [auth B]
SULFATE ION
O4 S
QAOWNCQODCNURD-UHFFFAOYSA-L
CA
(Subject of Investigation/LOI)

Query on CA



Download:Ideal Coordinates CCD File
C [auth A],
GA [auth B],
P [auth B]
CALCIUM ION
Ca
BHPQYMZQTOCNFJ-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.35 Å
  • R-Value Free:  0.233 (Depositor), 0.236 (DCC) 
  • R-Value Work:  0.205 (Depositor), 0.208 (DCC) 
  • R-Value Observed: 0.207 (Depositor) 
Space Group: P 43 2 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 150.455α = 90
b = 150.455β = 90
c = 304.948γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
PHENIXrefinement
PDB_EXTRACTdata extraction
XDSdata reduction
Aimlessdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute of Dental and Craniofacial Research (NIH/NIDCR)United StatesDE028349

Revision History  (Full details and data files)

  • Version 1.0: 2023-06-14
    Type: Initial release
  • Version 1.1: 2023-07-05
    Changes: Database references
  • Version 1.2: 2023-10-25
    Changes: Data collection